Coronary Artery Bypass Graft Market

Coronary Artery Bypass Graft Market (Product Type: On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG, and Conventional CABG) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Coronary Artery Bypass Graft Market Outlook 2031

  • The industry was valued at US$ 10.2 Bn in 2022
  • It is estimated to grow at a CAGR of 5.1% from 2023 to 2031 and reach US$ 15.8 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of coronary heart disease and growth in geriatric population are some of the key coronary artery bypass graft market drivers. Coronary artery bypass graft allows for the removal of fatty build-up and blockages in arteries through minimally invasive surgeries. Advancements in the surgical sector, including robotic surgeries, are fueling the demand for coronary artery bypass grafts, thereby augmenting market progress.

Growth in technological developments in the global healthcare sector, especially in developing countries, is likely to offer lucrative coronary artery bypass graft market opportunities to companies operating in the industry. Key players are investing substantially in the manufacture of polymer-based restorative devices for cardiovascular treatment. Thus, increase in investments in product development is a vital coronary artery bypass graft marketing strategy adopted by the leading companies.

Coronary Artery Bypass Graft Market

Market Introduction

Coronary artery bypass graft is a surgical procedure conducted for the treatment of heart diseases. The procedure increases blood flow and oxygen supply to the heart by diverting blood around clogged parts of the major arteries.

Coronary artery bypass surgery is performed to create a new path for blood flow to the heart. In this surgery, a healthy blood vessel from another body part is used to redirect blood around the blocked artery.

Adequate blood flow, lower risk of stroke, less possibility of respiratory diseases, and reduced chest pain and shortness of breath are some of the prominent advantages of the coronary artery bypass graft.

Single or multiple grafts are used in coronary surgeries depending on the number of blockages and severity of blood clotting in the arteries. These grafts are extensively employed during minimally invasive surgeries, as these surgeries entail fewer incisions and require less time to operate.

Rise in Prevalence of Coronary Heart Diseases Boosting Market Statistics

Coronary heart diseases are caused by blocked or interrupted blood supply to the heart due to a build-up of fatty substances in coronary arteries. Obstructive coronary artery diseases, non-obstructive artery diseases, and spontaneous coronary artery dissection are the major types of heart diseases that occur due to interrupted blood supply.

Growth in sedentary lifestyles, changes in eating habits, and increase in obesity are resulting in high prevalence of coronary heart diseases among adults and the geriatric population. Thus, rise in prevalence of coronary heart diseases among the geriatric population is driving the coronary artery bypass graft market revenue.

According to data published by the Journal of the American Heart Association in January 2023, more than 70% of people over 70 years of age are likely to develop cardiovascular diseases, and more than two-thirds would also have associated non-cardiovascular comorbidities. Thus, increase in geriatric population across the globe is driving the need for heart artery bypass, which in turn, is likely to spur the market dynamics.

Increase in Demand for Robotic Surgeries Augmenting Coronary Artery Bypass Graft Market Development

Robot-assisted surgeries allow surgeons to perform complex procedures with more precision. These are minimally invasive surgeries that are less risky and have smaller surgical cuts. Minimally invasive coronary artery bypass graft surgery ensures fewer incisions, reduced hospitalization period, less blood loss, and high surgical accuracy. Thus, surgeons are increasingly preferring minimally invasive procedures to enhance accuracy and ensure patient safety.

Development of healthcare facilities in emerging countries is augmenting the availability of coronary artery disease surgical treatment, thereby fostering the coronary artery bypass graft market growth.

Public healthcare organizations and governments are investing significantly in the improvement of healthcare infrastructure to meet the surging demand for advanced treatments for coronary diseases. For instance, Million Hearts, a national initiative by the Department of Health & Human Services, aims to prevent one million heart attacks and strokes within five years. The Million Hearts Cardiac Rehabilitation Collaborative (CRC) is an open forum of multi-disciplinary professionals taking action to help at least 70% of eligible patients participate in cardiac rehabilitation.

Regional Outlook

As per the regional coronary artery bypass graft market analysis, North America dominated the global landscape in 2022. Increase in awareness about cardiovascular diseases and rise in access to advanced medical facilities are likely to propel the coronary artery bypass graft industry share of the region during the forecast period.

According to the Centers for Disease Control and Prevention, around 695,000 people in the U.S. died from heart disease in 2021. About 1 in 20 adults aged 20 and older has coronary artery disease, and around 375,476 fatalities were recorded in 2021 due to CAD. Increase in prevalence of strokes and coronary heart diseases is fueling the demand for coronary artery bypass graft in North America.

Analysis of Key Players in Coronary Artery Bypass Graft Market

Companies operating in the global landscape are adopting the latest technologies to improve their product portfolio. They are investing substantially in the development of advanced products for usage in robotic surgeries. Leading coronary artery bypass graft market manufacturers are also conducting clinical trials to assess safety and efficacy of products.

Boston Scientific, Medtronic Plc, TERUMO CORPORATION, KARL STORZ GmbH & Co. KG, Sorin Group (LivaNova PLC), Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Edwards Lifesciences Corporation, MAQUET Holding B.V. & Co. KG, and Genesee Biomedical Inc. are the prominent players operating in the global landscape.

The coronary artery bypass graft market report scope covers these leading companies based on parameters such as company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In September 2022, Edwards Lifesciences Corporation, a leading medical technology company, launched SAPIEN 3 ULTRA RESILIA VALVE. This system incorporates Edward’s breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
  • In August 2022, Grand Pharmaceutical Group of China committed to invest € 15 Mn in Xeltis, a renowned medical device firm with its clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has created a polymer-based restorative device for cardiovascular treatment. The restorative device comprises heart valves and small-diameter blood vessels for coronary artery bypass graft surgery and hemodialysis vascular access.

Coronary Artery Bypass Graft Market Snapshot

Attribute Detail
Market Size in 2022 US$ 10.2 Bn
Market Forecast (Value) in 2031 US$ 15.8 Bn
Growth Rate (CAGR) 5.1%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • On-pump CABG
    • Off-pump CABG
    • Minimally Invasive Direct CABG
    • Conventional CABG
  • Device
    • Tissue Stabilizers
    • Heart Positioners
    • Refractors
    • Cannulas
    • Cardiopulmonary Bypass Machines
    • Endoscopic Vessel Harvesting Systems
    • Others
  • Technique
    • Traditional Vessel Harvesting
    • Endoscopic Vessel Harvesting (EVH)
  • End-user
    • Hospitals
    • Cardiology Clinics
    • Research & Academic Institutions
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
Companies Profiled
  • Medtronic Plc
  • TERUMO CORPORATION
  • KARL STORZ GmbH & Co. KG
  • Sorin Group (LivaNova PLC)
  • Boston Scientific
  • Ethicon US, LLC (Johnson & Johnson)
  • NeoGraft Technologies, Inc.
  • Edwards Lifesciences Corporation
  • MAQUET Holding B.V. & Co. KG
  • Genesee Biomedical Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global coronary artery bypass graft market in 2022?

It was valued at US$ 10.2 Bn in 2022

How is the coronary artery bypass graft sector expected to grow by 2031?

It is projected to register a CAGR of 5.1% from 2023 to 2031

What are the key factors driving the adoption of coronary artery bypass graft?

Rise in prevalence of coronary heart diseases and increase in demand for robotic surgeries

Which was the most lucrative region of the coronary artery bypass graft industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent coronary artery bypass graft manufacturers?

Boston Scientific, Medtronic Plc, TERUMO CORPORATION, KARL STORZ GmbH & Co. KG, Sorin Group (LivaNova PLC), Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Edwards Lifesciences Corporation, MAQUET Holding B.V. & Co. KG, and Genesee Biomedical Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Coronary Artery Bypass Graft Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Coronary Artery Bypass Graft Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Product Type

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. On-pump CABG

            6.3.2. Off-pump CABG

            6.3.3. Minimally Invasive Direct CABG

            6.3.4. Conventional CABG

        6.4. Market Attractiveness, by Product Type

    7. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Device

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Device, 2017–2031

            7.3.1. Tissue Stabilizers

            7.3.2. Heart Positioners

            7.3.3. Refractors

            7.3.4. Cannulas

            7.3.5. Cardiopulmonary Bypass Machines

            7.3.6. Endoscopic Vessel Harvesting Systems

            7.3.7. Others

            7.3.8. 7.4 Market Attractiveness, by Device

    8. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Technique

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Technique, 2017–2031

            8.3.1. Traditional Vessel Harvesting

            8.3.2. Endoscopic Vessel Harvesting (EVH)

        8.4. Market Attractiveness, by Technique

    9. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by End-user

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Cardiology Clinics

            9.3.3. Research & Academic Institutions

        9.4. Market Attractiveness, by End-user

    10. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Coronary Artery Bypass Graft Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. On-pump CABG

            11.2.2. Off-pump CABG

            11.2.3. Minimally Invasive Direct CABG

            11.2.4. Conventional CABG

        11.3. Market Attractiveness, by Product Type

        11.4. Market Value Forecast, by Device, 2017–2031

            11.4.1. Tissue Stabilizers

            11.4.2. Heart Positioners

            11.4.3. Refractors

            11.4.4. Cannulas

            11.4.5. Cardiopulmonary Bypass Machines

            11.4.6. Endoscopic Vessel Harvesting Systems

            11.4.7. Others

        11.5. Market Attractiveness, by Device

        11.6. Market Value Forecast, by Technique, 2017–2031

            11.6.1. Traditional Vessel Harvesting

            11.6.2. Endoscopic Vessel Harvesting (EVH)

        11.7. Market Attractiveness, by Technique

        11.8. Market Value Forecast, by End-user, 2017–2031

            11.8.1. Hospitals

            11.8.2. Cardiology Clinics

            11.8.3. Research & Academic Institutions

        11.9. Market Attractiveness, by End-user

        11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Product Type

            11.11.2. By Device

            11.11.3. By Technique

            11.11.4. By End-user

            11.11.5. By Country

    12. Europe Coronary Artery Bypass Graft Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. On-pump CABG

            12.2.2. Off-pump CABG

            12.2.3. Minimally Invasive Direct CABG

            12.2.4. Conventional CABG

        12.3. Market Attractiveness, by Product Type

        12.4. Market Value Forecast, by Device, 2017–2031

            12.4.1. Tissue Stabilizers

            12.4.2. Heart Positioners

            12.4.3. Refractors

            12.4.4. Cannulas

            12.4.5. Cardiopulmonary Bypass Machines

            12.4.6. Endoscopic Vessel Harvesting Systems

            12.4.7. Others

        12.5. Market Attractiveness, by Device

        12.6. Market Value Forecast, by Technique, 2017–2031

            12.6.1. Traditional Vessel Harvesting

            12.6.2. Endoscopic Vessel Harvesting (EVH)

        12.7. Market Attractiveness, by Technique

        12.8. Market Value Forecast, by End-user, 2017–2031

            12.8.1. Hospitals

            12.8.2. Cardiology Clinics

            12.8.3. Research & Academic Institutions

        12.9. Market Attractiveness, by End-user

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Product Type

            12.11.2. By Device

            12.11.3. By Technique

            12.11.4. By End-user

            12.11.5. By Country/Sub-region

    13. Asia Pacific Coronary Artery Bypass Graft Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. On-pump CABG

            13.2.2. Off-pump CABG

            13.2.3. Minimally Invasive Direct CABG

            13.2.4. Conventional CABG

        13.3. Market Attractiveness, by Product Type

        13.4. Market Value Forecast, by Device, 2017–2031

            13.4.1. Tissue Stabilizers

            13.4.2. Heart Positioners

            13.4.3. Refractors

            13.4.4. Cannulas

            13.4.5. Cardiopulmonary Bypass Machines

            13.4.6. Endoscopic Vessel Harvesting Systems

            13.4.7. Others

        13.5. Market Attractiveness, by Device

        13.6. Market Value Forecast, by Technique, 2017–2031

            13.6.1. Traditional Vessel Harvesting

            13.6.2. Endoscopic Vessel Harvesting (EVH)

        13.7. Market Attractiveness, by Technique

        13.8. Market Value Forecast, by End-user, 2017–2031

            13.8.1. Hospitals

            13.8.2. Cardiology Clinics

            13.8.3. Research & Academic Institutions

        13.9. Market Attractiveness, by End-user

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Product Type

            13.11.2. By Device

            13.11.3. By Technique

            13.11.4. By End-user

            13.11.5. By Country/Sub-region

    14. Latin America Coronary Artery Bypass Graft Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. On-pump CABG

            14.2.2. Off-pump CABG

            14.2.3. Minimally Invasive Direct CABG

            14.2.4. Conventional CABG

        14.3. Market Attractiveness, by Product Type

        14.4. Market Value Forecast, by Device, 2017–2031

            14.4.1. Tissue Stabilizers

            14.4.2. Heart Positioners

            14.4.3. Refractors

            14.4.4. Cannulas

            14.4.5. Cardiopulmonary Bypass Machines

            14.4.6. Endoscopic Vessel Harvesting Systems

            14.4.7. Others

        14.5. Market Attractiveness, by Device

        14.6. Market Value Forecast, by Technique, 2017–2031

            14.6.1. Traditional Vessel Harvesting

            14.6.2. Endoscopic Vessel Harvesting (EVH)

        14.7. Market Attractiveness, by Technique

        14.8. Market Value Forecast, by End-user, 2017–2031

            14.8.1. Hospitals

            14.8.2. Cardiology Clinics

            14.8.3. Research & Academic Institutions

        14.9. Market Attractiveness, by End-user

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Product Type

            14.11.2. By Device

            14.11.3. By Technique

            14.11.4. By End-user

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Coronary Artery Bypass Graft Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product Type, 2017–2031

            15.2.1. On-pump CABG

            15.2.2. Off-pump CABG

            15.2.3. Minimally Invasive Direct CABG

            15.2.4. Conventional CABG

        15.3. Market Attractiveness, by Product Type

        15.4. Market Value Forecast, by Device, 2017–2031

            15.4.1. Tissue Stabilizers

            15.4.2. Heart Positioners

            15.4.3. Refractors

            15.4.4. Cannulas

            15.4.5. Cardiopulmonary Bypass Machines

            15.4.6. Endoscopic Vessel Harvesting Systems

            15.4.7. Others

        15.5. Market Attractiveness, by Device

        15.6. Market Value Forecast, by Technique, 2017–2031

            15.6.1. Traditional Vessel Harvesting

            15.6.2. Endoscopic Vessel Harvesting (EVH)

        15.7. Market Attractiveness, by Technique

        15.8. Market Value Forecast, by End-user, 2017–2031

            15.8.1. Hospitals

            15.8.2. Cardiology Clinics

            15.8.3. Research & Academic Institutions

        15.9. Market Attractiveness, by End-user

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Product Type

            15.11.2. By Device

            15.11.3. By Technique

            15.11.4. By End-user

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Medtronic Plc

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. TERUMO CORPORATION

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. KARL STORZ GmbH & Co. KG

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Sorin Group (LivaNova PLC)

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Boston Scientific

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Ethicon US, LLC (Johnson & Johnson)

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. NeoGraft Technologies, Inc.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Edwards Lifesciences Corporation

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. MAQUET Holding B.V. & Co. KG

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Genesee Biomedical Inc.

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 03: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 05: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 08: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 9: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 10: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 13: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 14: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 15: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 18: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 19: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 20: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 24: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 25: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 28: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031

    Table 29: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 30: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn), by Region, 2022 and 2031

    Figure 02: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Product Type, 2022

    Figure 03: Global Coronary Artery Bypass Graft Market Value Share, by Product Type, 2022

    Figure 04: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Device, 2022

    Figure 05: Global Coronary Artery Bypass Graft Market Value Share, by Device, 2022

    Figure 06: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Technique, 2022

    Figure 07: Global Coronary Artery Bypass Graft Market Value Share, by Technique, 2022

    Figure 08: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022

    Figure 09: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022

    Figure 10: Global Coronary Artery Bypass Graft Market Value Share, by Region, 2022

    Figure 11: Global Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 13: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 14: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 15: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023-2031

    Figure 16: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 17: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023-2031

    Figure 18: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022

    Figure 19: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022

    Figure 20: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: North America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 23: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country, 2023–2031

    Figure 24: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Country, 2022 and 2031

    Figure 25: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 26: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 27: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 28: North America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 29: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 30: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031

    Figure 31: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 32: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 33: Europe Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 34: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 35: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 37: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 38: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 39: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 40: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 41: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031

    Figure 42: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 43: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 44: Asia Pacific Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 45: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 47: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 48: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 49: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 50: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 52: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031

    Figure 53: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 54: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 55: Latin America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 56: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 57: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 58: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 59: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 60: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 61: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 62: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 63: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031

    Figure 64: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 65: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 66: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 67: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 68: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 69: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 70: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031

    Figure 71: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 72: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 73: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 74: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031

    Figure 75: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 76: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved